Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients
- PDF / 949,056 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 93 Downloads / 211 Views
ORIGINAL ARTICLE
Clinical features of hemodialysis patients with COVID‑19: a single‑center retrospective study on 32 patients Xingguo Du1 · Hua Li1 · Liping Dong1 · Xiaojie Li1 · Ming Tian1 · Junwu Dong1 Received: 12 March 2020 / Accepted: 10 May 2020 © Japanese Society of Nephrology 2020
Abstract Objective We retrospectively analyzed the data of 32 hemodialysis patients with COVID-19 to clarify the epidemiological characteristics of this special population. Method The data of 32 hemodialysis patients with COVID-19, including epidemiological, demographic, clinical, laboratory, and radiological, were collected from the Blood Purification Department of Wuhan Fourth Hospital from February 3 to 16, 2020. Results Of the 32 patients, 23 were male, and the median age was 58 years; the median dialysis vintage was 33 months. Two groups were divided according to the patient’s primary renal disease: group 1 (16 patients with diabetic nephropathy), group 2 (12 patients with primary glomerulonephritis, 2 with obstructive kidney disease, 1 with hypertensive renal damage, and 1 with polycystic kidney). No significant differences were observed between the two groups in epidemiological characteristics, blood cell counts, and radiological performance. Hemodialysis patients are susceptible to COVID-19 at all ages, and patients with diabetes may be a high-risk population (50%). Common symptoms included fever (15 cases), cough (21 cases), and fatigue (7 cases). The blood lymphocyte count decreased in 84.6% of the patients (median: 0.765 × 109/L). Chest CT revealed ground-glass-like lesions in 18 cases, unilateral lung patchiness in 7 cases, bilateral lung patchiness in 7 cases, and pleural effusion in 2 cases. Conclusion Only 46.875% of the hemodialysis patients with COVID-19 had fever in the early stage; and diabetics may be the most susceptible population. A decrease in blood lymphocyte count and ground-glass opacity on chest CT scan is beneficial in identifying the high-risk population. Keywords Hemodialysis · Coronavirus disease 2019 · Clinical features · Blood routine test · Chest CT scan
Introduction * Ming Tian [email protected] * Junwu Dong [email protected] Xingguo Du [email protected] Hua Li [email protected] Liping Dong [email protected] Xiaojie Li [email protected] 1
Department of Nephrology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, People’s Republic of China
An unknown infectious pneumonia outbreak occurred in Wuhan, Hubei province, China, since December 2019, which were found from the South China seafood market and spread to the entire country. The sequencing of the lower respiratory tract samples of infected patients confirmed that it is a novel type of coronavirus, which was subsequently named as severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) by The International Committee on Taxonomy of Viruses (ICTV) [1–4]. Until February 21, 2020, a total of 75,571 individuals were definitely confirmed with coronavirus
Data Loading...
